This report aims to provide a comprehensive presentation of the global market for Cancer & Tumor Profiling and Pathways, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer & Tumor Profiling and Pathways. This report contains market size and forecasts of Cancer & Tumor Profiling and Pathways in global, including the following market information:
Global Cancer & Tumor Profiling and Pathways Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer & Tumor Profiling and Pathways market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Immunoassays Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer & Tumor Profiling and Pathways include Illumina, Inc. (US), QIAGEN N.V. (Germany), NeoGenomics Laboratories, Inc. (US), HTG Molecular Diagnostics, Inc. (US) and Sysmex Corporation (Japan), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer & Tumor Profiling and Pathways companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer & Tumor Profiling and Pathways Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer & Tumor Profiling and Pathways Market Segment Percentages, by Type, 2022 (%)
- Immunoassays
- Next Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- In-Situ Hybridization (ISH)
- Microarrays
- Mass Spectrometry
- Others
Global Cancer & Tumor Profiling and Pathways Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer & Tumor Profiling and Pathways Market Segment Percentages, by Application, 2022 (%)
Global Cancer & Tumor Profiling and Pathways Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer & Tumor Profiling and Pathways Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Cancer & Tumor Profiling and Pathways revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Cancer & Tumor Profiling and Pathways revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Illumina, Inc. (US)
- QIAGEN N.V. (Germany)
- NeoGenomics Laboratories, Inc. (US)
- HTG Molecular Diagnostics, Inc. (US)
- Sysmex Corporation (Japan)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer & Tumor Profiling and Pathways, market overview.
Chapter 2: Global Cancer & Tumor Profiling and Pathways market size in revenue.
Chapter 3: Detailed analysis of Cancer & Tumor Profiling and Pathways company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer & Tumor Profiling and Pathways in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
